NO952110L - Termisk granuleringsfremgangsmåte - Google Patents

Termisk granuleringsfremgangsmåte

Info

Publication number
NO952110L
NO952110L NO952110A NO952110A NO952110L NO 952110 L NO952110 L NO 952110L NO 952110 A NO952110 A NO 952110A NO 952110 A NO952110 A NO 952110A NO 952110 L NO952110 L NO 952110L
Authority
NO
Norway
Prior art keywords
granulation process
active substance
thermal granulation
thermal
comminuted
Prior art date
Application number
NO952110A
Other languages
English (en)
Other versions
NO952110D0 (no
Inventor
Ingrid Hurner
Peter Danz
Reinhard Walter
Joachim Maasz
Georg Frank
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO952110D0 publication Critical patent/NO952110D0/no
Publication of NO952110L publication Critical patent/NO952110L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/20—Extrusion means, e.g. for producing pharmaceutical forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)
  • Amplifiers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Det er beskrevet en fremgangsmåte for fremstilling av et direkte tabletterbart granulat, Inneholdende et virksomt stoff med lav smeltepunkt samt de nødvendige tablett-hjelpestoffene, hvorved man bearbeider blandingen av virksomt stoff og hjelpestoffer direkte ved hjelp av en smelteekstrudering til et homogent ekstrudat som deretter findeles til et granulat.
NO952110A 1994-05-30 1995-05-29 Termisk granuleringsfremgangsmåte NO952110L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4418837A DE4418837A1 (de) 1994-05-30 1994-05-30 Thermisches Granulierverfahren

Publications (2)

Publication Number Publication Date
NO952110D0 NO952110D0 (no) 1995-05-29
NO952110L true NO952110L (no) 1995-12-01

Family

ID=6519322

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952110A NO952110L (no) 1994-05-30 1995-05-29 Termisk granuleringsfremgangsmåte

Country Status (16)

Country Link
US (1) US5667807A (no)
EP (1) EP0686392B1 (no)
JP (1) JPH0847521A (no)
KR (1) KR950031043A (no)
AT (1) ATE173919T1 (no)
AU (1) AU693877B2 (no)
CA (1) CA2150304A1 (no)
CO (1) CO4290345A1 (no)
DE (2) DE4418837A1 (no)
DK (1) DK0686392T3 (no)
ES (1) ES2124460T3 (no)
FI (1) FI952578L (no)
MX (1) MX193007B (no)
NO (1) NO952110L (no)
SI (1) SI0686392T1 (no)
SV (1) SV1995000023A (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19509805A1 (de) * 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
DE19602206A1 (de) 1996-01-23 1997-07-24 Basf Ag Zubereitungen nichtsteroidaler Analgetika
DE19721467A1 (de) 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
DE59803468D1 (de) * 1997-11-28 2002-04-25 Knoll Ag Verfahren zur herstellung von lösungsmittelfreien nicht-kristallinen biologisch aktiven substanzen
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US8124124B2 (en) * 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
NZ535261A (en) * 2000-08-08 2004-12-24 Smithkline Beecham P A tablet comprising the hydrochloride salt of N-(1-nbutyl-4-piperidinyl)methyl]-3,4-[1,3]oxazino[3,2-a] indole-10-carboxamide
EP1252886A1 (en) * 2001-04-27 2002-10-30 Universiteit Gent Controlled release pharmaceutical pellet compositions
US6761905B2 (en) * 2001-05-01 2004-07-13 Wei Ming Pharmaceutical Mfg. Co., Ltd. Process for the preparation of direct tabletting formulations and aids
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
BR0307666A (pt) * 2002-02-14 2005-01-11 Glaxo Group Ltd Composição farmacêutica compreendendo n-[(1-n-butil-4-piperidinil)metil]-3,4-diidro-2h[1-3]oxazi no(3,2-a) indol-10-carboxamida ou sal e processo para esta compreendendo granulação seca
CA2509958A1 (en) * 2003-02-03 2004-08-19 Novartis Ag Pharmaceutical formulation
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
EP2704696A1 (en) 2012-03-26 2014-03-12 Glatt AG Taste-masked ibuprofen granules
WO2016042372A1 (en) 2014-09-17 2016-03-24 Steer Engineering Private Limited Effervescent composition and method of making it
US11219594B2 (en) * 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
GB201801415D0 (en) * 2018-01-29 2018-03-14 Univ Limerick Method and apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE463541B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
US5403593A (en) * 1991-03-04 1995-04-04 Sandoz Ltd. Melt granulated compositions for preparing sustained release dosage forms

Also Published As

Publication number Publication date
NO952110D0 (no) 1995-05-29
ATE173919T1 (de) 1998-12-15
DE4418837A1 (de) 1995-12-07
DE59504386D1 (de) 1999-01-14
CA2150304A1 (en) 1995-12-01
AU2027795A (en) 1995-12-07
JPH0847521A (ja) 1996-02-20
FI952578A0 (fi) 1995-05-26
ES2124460T3 (es) 1999-02-01
FI952578A7 (fi) 1995-12-01
SI0686392T1 (en) 1999-04-30
FI952578L (fi) 1995-12-01
SV1995000023A (es) 1996-04-11
MX193007B (en) 1999-08-13
EP0686392B1 (de) 1998-12-02
AU693877B2 (en) 1998-07-09
CO4290345A1 (es) 1996-04-17
KR950031043A (ko) 1995-12-18
EP0686392A1 (de) 1995-12-13
DK0686392T3 (da) 1999-08-16
US5667807A (en) 1997-09-16

Similar Documents

Publication Publication Date Title
DK108888D0 (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
SE8603247D0 (sv) Farmaceutiskt granulat
NO174876C (no) Fremgangsmåte for fremstilling av et medikament i form av granuler basert på fenofibrat, innbefattende en inert kjerne
MX193007B (en) Thermal granulation process
AU5523599A (en) Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
DK0560092T3 (da) Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
UA18251A (uk) Спосіб одержаhhя таблеток з безперервhим виділеhhям лікарського засобу
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
DK0391374T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
FR2450606A1 (fr) Procede de granulation de la trans-d1-1-hydroxy-3- (1',1'-dimethylheptyl)-6,6-dimethyl-6a, 7, 8, 9, 10, 10a-hexahydrodibenzo(b,d)pyran-9-one (nabilone)
FR2705963B1 (fr) Dérivés sulfonés de cyclomalto-oligosaccharides, leur procédé de préparation et support de substances actives contenant ces dérivés.
NO178362C (no) Fremgangsmåte for fremstilling av tabletter og granulat inneholdende mesna som virksomt stoff
GEP20033078B (en) Controlled-Release Compositions of Betahistine
WO1997010810A3 (en) Pharmaceutical granules
DZ2077A1 (fr) Procédé nouveau pour formuler des formes posologiques solides, et formes posologiques ainsi produites.
EP0609091A3 (en) Process for the preparation of statistical cycloolefin copolymer granules.
FR2653774B1 (fr) Procede de granulation des polysaccharides.
FR2620694B1 (fr) Procede de granulation du soufre et granulateur de soufre
NO874697D0 (no) Fremgangsmaate og anordning for granulering og granulert produkt.
FR2706128B1 (fr) Procédé de préparation de déjections animales, déjections animales désodorisées et leur utilisation .
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives
SE9502446D0 (sv) Granulating apparatus; granulating procedure; and granulated product
UA13210A (uk) Спосіб одержаhhя твердої лікувальhої форми дігідропірідіhу а у вигляді порошку, граhул або таблеток